Antidepressant (N06A) prescribing changes from 2014 to 2022. by Dainty Ei (22265317)

Subjects:

Regional differences in percentage changes of N07BC drug prescribing rates during the pandemic. by Dainty Ei (22265317)

Subjects:

Regional differences in N07B drug prescribing rate percentage changes during the pandemic. by Dainty Ei (22265317)

Subjects:

Drugs used in alcohol dependence (N07BB) prescribing changes from 2014 to 2022 (males). by Dainty Ei (22265317)

Subjects:

Regional differences in percentage changes of N07BB drug prescribing rates during the pandemic for females. by Dainty Ei (22265317)

Subjects:

Regional differences in percentage changes of N07BB drug prescribing rates during the pandemic for males. by Dainty Ei (22265317)

Subjects:

Scatterplots of N07BA (nicotine dependence drugs) patient differences by regions – the year 2022. by Dainty Ei (22265317)

Subjects:

Regional differences in percentage changes of N07BB drug prescribing rates during the pandemic (both genders). by Dainty Ei (22265317)

Subjects:

Fixed-effects panel regression results for nicotine dependence drug prescribing. by Dainty Ei (22265317)

Subjects:

Scatterplots of N07BA (nicotine dependence drugs) patient differences by regions – the year 2021. by Dainty Ei (22265317)

Subjects:

Population as of 1 November, number by age, sex, year, and region. by Dainty Ei (22265317)

Subjects:

Drugs used in nicotine dependence (N07BA) prescribing changes from 2014 to 2022. by Dainty Ei (22265317)

Subjects:

Scatterplots of N07BA (nicotine dependence drugs) patient differences by regions – the year 2020. by Dainty Ei (22265317)

Subjects:

Drugs used in opioid dependence (N07BC) prescribing changes from 2014 to 2022. by Dainty Ei (22265317)

Subjects:

Demographic information of participants. by Zixia Bu (21475019)

“…The positive correlation between HSK and PA did not change significantly (r = 0.15, r = 0.18, P < 0.01). The positive correlation of PA itself decreased over time (r = 0.83, r = 0.76, P < 0.01). …”

Total organic carbon and phenolic content of raw materials and fruit body cultivated (see S2 in S2 File for reference). by Caglar Akcay (6910697)

Subjects:

Spawn run time, earliness, yield, biological efficiency and dry matter of mushroom fruit body (see S1 in S2 File for reference). by Caglar Akcay (6910697)

Subjects:

S2 File - Valorization of various lignocellulosic wastes to <i>Ganoderma lucidum</i> (Curtis) P. Karst (Reishi Mushroom) cultivation and their FT-IR assessments by Caglar Akcay (6910697)

Subjects:

Between the PCSO-524 group and the placebo group unpaired comparisons of the change between visits of quality of life and respiratory variables scores. by Nattapon Riengvirodkij (11268720)

Subjects:

S1 File - Valorization of various lignocellulosic wastes to <i>Ganoderma lucidum</i> (Curtis) P. Karst (Reishi Mushroom) cultivation and their FT-IR assessments by Caglar Akcay (6910697)

Subjects: